Tag: Benefit

Categories
Health

Beforehand contaminated individuals would profit from vaccines

Previously infected people would benefit from vaccines

Dr. Scott Gottlieb believes people who have previously been infected with coronavirus would still benefit from receiving Covid vaccines.

In Tuesday’s interview on CNBC’s “Squawk Box,” the former Food and Drug Administration commissioner acknowledged that some individuals may think their antibodies generated from having the disease offer enough protection against future infection or illness and, as a result, forgo getting the Covid inoculation.

The reason to still receive the vaccine is “two-fold,” contended Gottlieb, who serves on the board of vaccine maker Pfizer.

“One, we believe the vaccine provides a more durable and broader immunity, so it’s going to protect you better against the variants,” he said, alluding to the highly transmissible delta variant, which is causing concern for public health officials.

“Two, if you’ve been previously infected and even if you get a single dose of the vaccine — forget getting both doses of the vaccine, just a single dose of the vaccine — you get a very robust immune response,” Gottlieb said.

Pfizer’s vaccine requires two shots for fully immunity protection, as does Moderna’s vaccine. Johnson & Johnson makes a single-dose vaccine. Those are the only three vaccines approved for emergency use in the U.S.

“It’s sort of the best of both worlds if you’ve been previously infected and you get vaccinated,” said Gottlieb, who led the FDA from 2017 to 2019 in the Trump administration. “At least with one dose, you do develop a broad, very deep, very durable immunity based on the data that we’ve seen so far, so there’s still a lot of compelling reasons why you’d want to get vaccinated even if you’ve been previously infected.”

More than 157 million people in the U.S., or 47.4% of the population, have been fully vaccinated against Covid, according to data compiled by the Centers for Disease Control and Prevention. Around 182.4 million people, or nearly 55% of the population, have received at least one dose.

After an aggressive push this spring to deliver the Covid shots to Americans, the pace of uptake slowed. In response, state and local officials — and businesses, too — launched various promotional efforts to encourage vaccination.

Nevertheless, among some people, hesitancy remains. According to the CDC, as of last week, about 1,000 counties in the U.S. had less than 30% of residents vaccinated.

The increasing presence of the delta variant, in both the U.S. and across the globe, adds urgency to calls for more people to get vaccinated. The variant, first discovered in India, has shown to make the vaccines slightly less effective, but still provide protection against severe disease, especially.

“We expect to see increased transmission in these communities unless we can vaccinate more people,” CDC Director Dr. Rochelle Walensky said Thursday, referring to those roughly 1,000 U.S. counties with low vaccination rates.

“Preliminary data over the last six months suggest 99.5% of deaths from Covid-19 in the states have occurred in unvaccinated people,” she added. “The suffering and loss we are now seeing is nearly entirely avoidable.”

Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic testing start-up Tempus, health-care tech company Aetion Inc. and biotech company Illumina. He also serves as co-chair of Norwegian Cruise Line Holdings’ and Royal Caribbean’s “Healthy Sail Panel.”

Categories
Entertainment

Kylie Jenner, Travis Scott Deliver Stormi to Parsons Profit

Kylie Jenner, Travis Scott Bring Stormi to Parsons Benefit

Um, excuse me, are Travis Scott and Kylie Jenner officially back together? On Tuesday night, the former couple made an appearance at the 72nd Annual Parsons Benefit in NYC where Travis was accepting an award. They walked the red carpet together with their 3-year-old daughter Stormi — their first event as a family of three in nearly two years since Kylie and Travis split in October 2019.

Rumors about Kylie and Travis rekindling their romance have circled for some time now, and according to E! News Travis all but confirmed this speculation in his acceptance speech. “Stormi, I love you and wifey, I love you,” he said. Wifey, you say? I love you, you say? Iiiinteresting. Kylie also shared a cozy photo of herself and Travis at the event, captioned, “24 hours in NYC.” The couple hasn’t confirmed their relationship publicly, but all signs point to a flirty reconciliation. Check out more photos from their night on the red carpet, ahead.

Categories
Politics

U.S. Chamber of Commerce rips $300 jobless profit, requires repeal

U.S. Chamber of Commerce rips $300 jobless benefit, calls for repeal

A help call sign is posted on a taco stand in Solana Beach, California.

Mike Blake | Reuters

The largest corporate lobby group in America on Friday accused $ 300 a week of unemployment benefits for tricking Americans into staying home and April’s far weaker-than-expected job report.

“The disappointing employment report makes it clear that the pay of people who do not work is dampening the stronger labor market,” said the US Chamber of Commerce in the hours after the Labor Department published its April 2021 employment report.

“One step that policymakers should take now is to end the additional $ 300 weekly unemployment benefit,” added the lobby group. “Based on the Chamber’s analysis, the $ 300 benefit means that roughly one in four recipients takes home more unemployment than they earned.”

A chamber spokesman confirmed to CNBC that it will use similar messages to lobby the White House and Capitol Hill to end the payout.

The group’s attack on federal unemployment benefits came hours after the Labor Department reported that total non-farm employment rose by 266,000 last month, well below the 1 million Dow Jones polled economists expected.

CNBC policy

Read more about CNBC’s political coverage:

The Biden government has pushed back arguments like those of the Chamber. Labor Secretary Marty Walsh, who appeared on CNBC Friday, dismissed arguments from Republicans and corporate groups that the increased unemployment benefits are encouraging potential workers to stay home.

Treasury Secretary Janet Yellen also waved such criticisms, telling reporters Friday afternoon that she disagreed that the unemployment benefit increase “is really the factor that makes a difference”.

“When you look at states or sectors or workers, if it is really the added benefits that are hindering hiring, expect it to be either in states or for workers in or sectors where the replacement rate is due [unemployment insurance] is very high – you would expect the placement rates to be lower, “she said.” In fact, you see exactly the opposite. “

Minnesota-born Democrat Ilhan Omar was cynical about the Chamber’s criticism of the $ 300 weekly benefit.

For much of the past year, millions of unemployed Americans have qualified for special federal unemployment benefits to replace income lost from layoffs during the Covid-19 pandemic.

The first such federal unemployment benefit began under former President Donald Trump in March 2020 when he signed the CARES bill. This law gave unemployed Americans a weekly allowance of $ 600, which in many cases was a higher income than workers received while working full-time.

Senator Bernie Sanders, I-Vt., Countered that companies should pay higher wages to their workers instead.

President Joe Biden’s US $ 1.9 trillion bailout plan, which went into effect in March, provides unemployment benefits of $ 300 per week. Without additional government intervention, this benefit will expire at the beginning of September.

Some economists and many Republicans have accused the benefit of deterring Americans from returning to the jobs they held before the pandemic.

For example, South Carolina governor Henry McMaster earlier this week ordered the state’s Department of Employment and Labor to withdraw from the federal government’s pandemic programs by the end of June.

“This labor shortage is caused in large part by the additional unemployment benefits that the federal government is providing applicants with on top of their state unemployment benefits,” McMaster said in a press release Thursday.

“What was meant to be short-term financial assistance to vulnerable and displaced people during the height of the pandemic has become a dangerous federal claim that encourages and pays workers to stay at home rather than encourage them to return to work. ” he added.

Categories
Business

Airways may gain advantage when the E.U. eases restrictions on journey.

Airlines could benefit when the E.U. eases restrictions on travel.

US airlines have been empowered with the return of customers looking to travel within or outside of its borders. However, the country’s largest airlines continue to lament the loss of two particularly lucrative businesses: international travel and business travel. At least one of them could recover this summer.

In an interview with the New York Times over the weekend, Ursula von der Leyen, the president of the European Commission, said she expected the European Union to ease travel restrictions on vaccinated American tourists, which could allow the aviation industry to make money at its busiest Travel season of the year.

“International long-haul aviation represents a significant opportunity for United,” United Airlines chief commercial officer Andrew Nocella told investors last week. “We have seen in the past few weeks that immediately after a country provides evidence of a vaccine, recreational demand quickly returns to 2019 levels.”

American Airlines and United earlier this month announced that international travel remained roughly 80 percent lower than in 2019. They and other airlines expect strong domestic demand this summer, and the restoration of transatlantic travel could be an urgent matter for the industry needed boost to give it works to generate profits again.

American, Delta Air Lines and United all reported losses of more than $ 1 billion for the first three months of the year. Southwest Airlines reported a small profit of $ 116 million, despite the CEO saying the airline would have lost $ 1 billion without government assistance.

The news of the reopening of the EU to vaccinated American tourists was also welcomed by Willie Walsh, director general of the International Air Transport Association, a global group in the aviation industry, who said it could bode well for other airlines too.

In a statement, he said coordination between the European Commission and industry is essential “so that airlines can plan within public health benchmarks and schedules that allow unconditional travel for those vaccinated,” not just Americans but also for passengers from other countries.

Categories
Health

NIH halts trial of Covid plasma remedy after researchers discovered no profit

NIH halts trial of Covid plasma treatment after researchers found no benefit

Convalescent plasma from a patient with recovered coronavirus disease (COVID-19) is seen at the Central Seattle Donor Center of Bloodworks Northwest during the outbreak in Seattle, Washington on April 17, 2020.

Lindsey Wasson | Reuters

The National Institutes of Health announced Tuesday that they had abandoned a study testing convalescent plasma in patients with mild to moderate Covid-19 symptoms after an independent panel of experts concluded it was unlikely to be beneficial.

The independent data and safety watchdog met on February 25 to review the data and found that while plasma treatment did no harm, it was unlikely to be of benefit to this patient population, the NIH said in a press release. After the meeting, the DSMB recommended that the NIH no longer enroll new patients in the study, the agency said.

Scientists and public health officials had previously said they were skeptical that convalescent plasma would be an effective treatment for patients with Covid, even after the Food and Drug Administration issued emergency approval for the treatment in August and former President Donald Trump said it was ” Breakthrough “denounced. “

At the time, Dr. Scott Gottlieb, a former FDA commissioner, said the treatment could help patients but “doesn’t look like a home run”. He agreed that convalescent plasma “certainly” met the standard for an emergency permit “in the context of a public health emergency.”

The plasma, taken from patients who have recovered from Covid-19 and who have developed antibodies to the virus, is infused into sick patients. Scientists had hoped it would help boost immune systems in these patients to fight the virus.

In January, REMAP-CAP, an international clinical trial investigating possible treatments for Covid, discontinued the study testing convalescent blood plasma after the study’s examiners found no benefit. The decision by REMAP-CAP was made after an initial analysis of more than 900 critically ill study participants in the intensive care unit showed that treatment with the product did not noticeably improve the health of the patients.

The NIH study was conducted in 47 US hospitals emergency departments and had 511 of the 900 participant recruitment targets enrolled. After study participants received either the plasma or a placebo, the researchers tracked whether participants needed additional emergency or urgent treatment, had to be hospitalized, or died within 15 days of the start of the study.

Categories
World News

HSBC names 2 international locations that tackled Covid and can profit in 2021

HSBC names 2 countries that tackled Covid and will benefit in 2021

SINGAPORE – Singapore and Vietnam successfully battled coronavirus in 2020 and are likely to maintain the situation for next year, an economist said this week.

“These two countries are probably the most positive,” said HSBC Global Research’s Joseph Incalcaterra when asked which Southeast Asian countries can keep Covid under control and smoothly introduce vaccines.

Singapore “has brought its previous outbreaks under control and … at a time when most countries in the world are actually tightening restrictions, Singapore is going the opposite way,” ASEAN’s chief economist told CNBC’s “Squawk Box Asia” on Tuesday.

The city-state entered the third phase of its reopening this week and now allows gatherings of eight out of five people. Tourist attractions can increase their operating capacity from 50% to 65% once they are approved by the authorities.

People swim on a beach in East Coast Park on December 25, 2020 in Singapore.

Suhaimi Abdullah | Getty Images News | Getty Images

Incalcaterra said Singapore also has an effective vaccination strategy.

“Thanks to a relatively small population, the prospects for Singapore for 2021 are extremely good by comparison,” he said.

Prime Minister Lee Hsien Loong said there will be enough vaccines for “everyone in Singapore” by the third quarter of 2021. The country was the first in Asia to receive a shipment of Pfizer BioNTech vaccines on December 21, 2020.

HSBC’s Incalcaterra also praised Vietnam’s handling of the virus, saying its response to the pandemic enabled the country to maintain its reputation as a “very good destination” for foreign direct investment. The country has been viewed as an alternative manufacturing hub for companies looking to move out of China.

“We have seen that FDI remains very resilient in Vietnam this year,” he said.

Overall, however, Southeast Asia is unlikely to benefit from a vaccine in the near future due to logistical difficulties in rural parts of the region. “It is very unlikely that a significant portion of the population will be vaccinated in 2021,” he said.

Deep damage

Separately, Incalcaterra said Southeast Asia had been “hit very hard” this year. “From a domestic perspective, the traditional consumer motor of these economies is no longer intact.”

“We really don’t have a good view of the short-term recovery considering how deep the damage is,” he added.

While electronic exports have been “relatively bright,” HSBC is focusing on how quickly consumption and investment in the region can recover.

He said countries had “very ambitious infrastructure programs” to make the region a “reliable base for manufacturing”. These projects have stalled because of the coronavirus.

“Until the virus is under control … we won’t see this investment engine regain traction,” he said. “I think this is the biggest short-term obstacle to growth in Southeast Asia.”

Categories
Health

Covid Affected person Examine Reveals Some Profit From an Arthritis Drug

Covid Patient Study Shows Some Benefit From an Arthritis Drug

Adding an arthritis drug called baricitinib to Covid treatment regimens that contains the antiviral drug remdesivir can cut recovery times by a day or more, especially for those who are seriously ill, according to a study published Friday.

The results of a government-sponsored clinical trial were released more than three weeks after the Food and Drug Administration received an emergency approval for double treatment. Earlier this month, some experts said they were uncomfortable using medication without a chance to review the underlying data backing their performance. Last month, the World Health Organization also recommended rejecting remdesivir for treating Covid patients as there was no evidence of its use.

In previous press releases, limited results were disclosed showing that hospitalized Covid patients treated with baricitinib and remdesivir recovered one day faster than those who received remdesivir alone.

Some questioned the adoption of the combination treatment because baricitinib came at a high price – which could be around $ 1,500 per patient – and also cited side effects like blood clots. Several doctors also wondered if adding baricitinib would be worth it, since steroids like dexamethasone were cheap and widely available. Both baricitinib and dexamethasone are believed to suppress the excessive inflammation that causes many severe cases of Covid.

The new paper, published in the New England Journal of Medicine, adds some granularity to the results and shows that certain subsets of patients benefited far more from the addition of baricitinib than others. The study included more than 1,000 hospital patients with Covid, all of whom received remdesivir. People who were sick enough to need high doses of supplemental oxygen or non-invasive ventilation recovered eight days faster when baricitinib was included in their medication.

In these groups, “I think the data clearly support a role for baricitinib,” said Dr. Boghuma Kabisen Titanji, an infectious disease doctor at Emory University who pioneered early studies of baricitinib against the coronavirus.

Dr. Titanji also noted that the data suggested that certain patients may be less likely to die or need a ventilator when taking baricitinib in addition to remdesivir. However, like those showing faster recovery times, these results were inconsistent among study participants.

Dr. Lauren Henderson, a pediatric rheumatologist at Boston Children’s Hospital, said she was encouraged by the results and the prospect of another option in the coronavirus treatment arsenal.

She and several other experts added that they may still have a tendency to use dexamethasone as a treatment for seriously ill Covid-19 patients who needed respiratory support.

In contrast to baricitinib, studies have shown that dexamethasone inhibits mortality in seriously ill Covid patients. It’s also inexpensive and easy to get hold of, while baricitinib is more of a specialty drug and may pose barriers to the supply chain, said Dr. Erin McCreary, Infectious Disease Pharmacist at the University of Pittsburgh.

New treatments for Covid-19

Things to know about Covid-19 treatment

Confused By The Terms To Treat Covid-19? Let us help:

    • ACE-2: A protein that sits on the surface of certain types of human cells. The coronavirus has to bind to ACE-2 in order to enter cells.
    • Adverse event: A health problem that occurs in volunteers in a clinical trial with a vaccine or drug. An adverse event is not always caused by the treatment tested in the study.
    • Antibody: A protein produced by the immune system that can attach to a pathogen such as the coronavirus and prevent it from infecting cells.
    • Antiviral drug: A drug that affects the ability of a virus to replicate in cells. The first drug approved in the United States for Covid-19, Remdesivir, is antiviral.
    • Approval, Licensing, and Approval for Emergency Use: Medicines, vaccines and medical devices cannot be sold in the US for no profit approval by the Food and Drug Administration, also known as Licensing. After a company submits the results of clinical studies to the FDA for review, the agency decides whether the product is safe and effective. This process usually takes many months. If the country faces an emergency – like a pandemic – a company can file an application instead Emergency approvalthat can be granted much faster.
    • Compassionate Use: A term used to describe treatments given to seriously ill people even though they have not yet been approved for that use by the Food and Drug Administration.
    • Cytokine storm: An overactive immune system reaction that can lead to massive inflammation and tissue damage. Cytokine storms can be responsible for many of the severe cases of Covid-19, and a number of researchers are testing drugs that may calm them down.
    • Interferon: A molecule of the immune system. Certain types of interferons can cause inflammation in the body while others can contain it. Still other types can stimulate cells to strengthen their defenses against viruses. Researchers are investigating whether treating synthetic interferons can help people fight off the coronavirus.
    • Monoclonal Antibodies: Monoclonal antibodies made in a laboratory mimic the natural antibodies made by the immune system. A number of companies have developed these treatments for Covid-19. President Trump received Regeneron’s antibody treatment soon after the disease was diagnosed.
    • Phases 1, 2 and 3 studies: Clinical trials typically take place in three phases. Phase 1 studies typically involve a few dozen people to determine whether a vaccine or drug is safe. In Phase 2 trials that involve hundreds of people, researchers can try different doses and take more measurements of the vaccine’s effects on the immune system. Phase 3 trials, involving thousands or tens of thousands of volunteers, determine the safety and effectiveness of the vaccine or medicine by waiting to see how many people are protected from the disease it is intended to be used against.
    • Placebo: A substance with no therapeutic effect that is widely used in clinical trials. For example, to see if a vaccine can prevent Covid-19, researchers can inject the vaccine into half of their volunteers while the other half are given a placebo with salt water. You can then compare how many people are infected in each group.
    • Post-market surveillance: The surveillance that occurs after a vaccine or drug has been approved and regularly prescribed by doctors. This typically confirms that the treatment is safe. Rarely, side effects are noted in certain groups of people that were overlooked during clinical trials.
    • Preclinical Research: Studies that take place prior to the start of a clinical trial typically include experiments that test a treatment on cells or animals.
    • Test protocol: A series of procedures that must be performed during a clinical trial.
    • Retrospective study: A study that analyzes data collected in the past to determine how effective a treatment is. Retrospective studies can provide useful information, but they are not as definitive as randomized clinical studies.
    • Spike protein: A protein that sits on the surface of coronaviruses. The spike protein binds to the ACE-2 receptor on human cells using a region called the receptor binding domain (RBD). As soon as the protein accumulates, the virus can enter the cell. Many vaccines and monoclonal antibody treatments are designed to stick to the tip.
    • Standard of care: A treatment that is accepted by medical experts as an appropriate method to treat a specific type of disease. Once a standard for treating a disease is established, new experimental treatments are usually tested against it rather than a placebo.

Several experts pointed to another study by the National Institutes of Health that seeks to directly compare two combination treatment regimens: one in which hospital patients receive remdesivir and baricitinib, and one in which remdesivir is paired with dexamethasone. Dr. McCreary also noted the importance of studying patients receiving both baricitinib and dexamethasone “to see if there is any incremental benefit.”

Dr. Andre Kalil, an infectious disease doctor at the University of Nebraska Medical Center and lead researcher on the new paper, noted that while dexamethasone had already become a widely accepted treatment for Covid-19, the steroid still needed further study. He cited “a variety of serious safety issues” with the drug that warranted thorough investigation.

Like other steroids, dexamethasone, which largely reduces inflammation, can be associated with a variety of undesirable side effects, including worsening conditions like diabetes or osteoporosis.